Cargando…

Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach

Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Guigao, Yi, Lang, Zhang, Kuo, Wang, Lunan, Zhang, Rui, Xie, Jiehong, Li, Jinming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517881/ https://www.ncbi.nlm.nih.gov/pubmed/26218263 http://dx.doi.org/10.1371/journal.pone.0134174

Ejemplares similares

National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China
por: Lin, Guigao, et al.
Publicado: (2016)

Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China
por: Yi, Lang, et al.
Publicado: (2016)

Results of the National External Quality Assessment for Toxoplasmosis Serological Testing in China
por: Zhang, Kuo, et al.
Publicado: (2015)

Application of HTB-SiHa Cells Transfected with a Recombinant Plasmid for External Quality Assessment of Chlamydia trachomatis PCR
por: Zhang, Kuo, et al.
Publicado: (2014)

External Quality Assessment for the Detection of Measles Virus by Reverse Transcription-PCR Using Armored RNA
por: Zhang, Dong, et al.
Publicado: (2015)

Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection
por: Li, Yulong, et al.
Publicado: (2016)

Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect
por: Zhang, Kuo, et al.
Publicado: (2017)

External quality assessment for the molecular detection of MERS-CoV in China
por: Zhang, Lei, et al.
Publicado: (2016)

Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
por: Yao, Yanlan, et al.
Publicado: (2015)

Prevalence of HBV DNA among 20 million seronegative blood donations in China from 2010 to 2015
por: Liu, Chao, et al.
Publicado: (2016)

The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China
por: Zhang, Rui, et al.
Publicado: (2016)

Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma
por: Chang, Le, et al.
Publicado: (2016)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy
por: Tajima, Hayato, et al.
Publicado: (2018)

The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
por: Alkattan, Abdullah, et al.
Publicado: (2021)

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
por: Russmann, Stefan, et al.
Publicado: (2020)

Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI
por: Zhang, Qifeng, et al.
Publicado: (2018)

The CYP2C19(∗)1/(∗)2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers
por: Nasyuhana Sani, Yanti, et al.
Publicado: (2013)

CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British–South Asians Treated With Clopidogrel
por: Magavern, Emma F., et al.
Publicado: (2023)

Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China
por: Su, Qiang, et al.
Publicado: (2019)

An Initial Survey of the Performances of Exome Variant Analysis and Clinical Reporting Among Diagnostic Laboratories in China
por: Zhang, Kuo, et al.
Publicado: (2020)

Increased Kappa/Lambda Hybrid Antibody in Serum Is a Novel Biomarker Related to Disease Activity and Inflammation in Rheumatoid Arthritis
por: Yi, Lang, et al.
Publicado: (2016)

Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer
por: Hao, Mingju, et al.
Publicado: (2016)

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
por: Bauer, Tim, et al.
Publicado: (2011)

Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study
por: Liao, Yi-Ju, et al.
Publicado: (2022)

Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis
por: Yao, Jia-Chen, et al.
Publicado: (2018)

CYP2C19 polymorphisms and lipoproteins associated with clopidogrel resistance in children with Kawasaki disease in China: A prospective study
por: Zhang, Mingming, et al.
Publicado: (2022)

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
por: Chang, Rong, et al.
Publicado: (2022)

Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
por: Wang, Bin, et al.
Publicado: (2018)

External Quality Assessment of Molecular Detection of Ebola Virus in China
por: Wang, Guojing, et al.
Publicado: (2015)

Correction: External Quality Assessment of Molecular Detection of Ebola Virus in China
por: Wang, Guojing, et al.
Publicado: (2016)

Feasibility of a Microarray-Based Point-of-Care CYP2C19 Genotyping Test for Predicting Clopidogrel On-Treatment Platelet Reactivity
por: Chae, Hyojin, et al.
Publicado: (2013)

Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus
por: Zhang, Kuo, et al.
Publicado: (2010)

Preparation of multiplexed control materials for cancer mutation analysis by genome editing in GM12878 cells
por: Lin, Guigao, et al.
Publicado: (2021)

Baseline P2Y12 reactivity, kidney function, and CYP2C19 genotype determine clopidogrel responsiveness in acute stroke
por: Lee, Yi-Chung, et al.
Publicado: (2023)

Re-Evaluation of Genotyping Methodologies in Cattle: The Proficiency of Imputation
por: Gershoni, Moran, et al.
Publicado: (2023)

Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
por: Li, Changqing, et al.
Publicado: (2021)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
por: Westergaard, Niels, et al.
Publicado: (2021)

Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection
por: Sun, Shipeng, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gab75q2grhc6n65f8qq984hej6